Romero JM, Magrill J, Kalashnikov N, Luo YZ, Chen OJ, Busque S, Ma R, Atallah A, Lazaratos AM, Mendelson D, Wilson L, Deshmukh S, Taifour T, Sorin M, Arthur I, Kuasne H, Levett JY, Wang Y, Seufferlein T, Kleger A, Gout J, Michels AK, Brugarolas J, Poshusta ZS, Hogenson TL et al. (2026)
Comparative analysis of patient-derived organoids and patient-derived xenografts as avatar models for predicting response to anti-cancer therapy
Cancer Treat Rev, 149, 103190 (in press)
DOI 10.1016/j.ctrv.2026.103190, PubMed 42497819

Panagopoulos I, Stranger A, Sveen A, Jareid M, Kidd SG, Bischof K, Taskén K, Dørum A, Davidson B, Lothe RA, Skotheim RI, Johannessen B (2026)
Fusion gene heterogeneity and kinase enrichment in high-grade serous carcinomas
Neoplasia, 79, 101332
DOI 10.1016/j.neo.2026.101332, PubMed 42349107

Kryeziu K, Klokkerud SK, Totland MZ, Moosavi SH, Reims HM, Bergsland CH, Eilertsen IA, Smeby J, Lassen K, Lundesgaard KK, Syversveen T, Brændengen M, Nesbakken A, Guren TK, Yaqub S, Sveen A, Lothe RA (2026)
Patient-derived organoids from metastatic colorectal cancer mirror tumor heterogeneity and predict patient survival and drug sensitivity
Cell Rep Med, 7 (6), 102840
DOI 10.1016/j.xcrm.2026.102840, PubMed 42208542